T. Rowe Price Associates’s Stryker SYK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.3B Sell
10,037,137
-80,927
-0.8% -$29.1M 0.38% 45
2025
Q4
$3.56B Sell
10,118,064
-879,884
-8% -$321M 0.38% 43
2025
Q3
$4.07B Sell
10,997,948
-900,546
-8% -$348M 0.44% 34
2025
Q2
$4.71B Sell
11,898,494
-232,724
-2% -$87.1M 0.53% 25
2025
Q1
$4.52B Buy
12,131,218
+1,021,496
+9% +$389M 0.56% 26
2024
Q4
$4B Buy
11,109,722
+54,693
+0.5% +$20.3M 0.46% 34
2024
Q3
$3.99B Sell
11,055,029
-642,325
-5% -$222M 0.46% 39
2024
Q2
$3.98B Sell
11,697,354
-182,543
-2% -$61.8M 0.48% 35
2024
Q1
$4.25B Sell
11,879,897
-661,948
-5% -$223M 0.52% 28
2023
Q4
$3.76B Buy
12,541,845
+642,178
+5% +$180M 0.5% 34
2023
Q3
$3.25B Sell
11,899,667
-388,366
-3% -$111M 0.48% 36
2023
Q2
$3.75B Sell
12,288,033
-2,030,404
-14% -$586M 0.52% 33
2023
Q1
$4.09B Sell
14,318,437
-645,704
-4% -$171M 0.61% 29
2022
Q4
$3.66B Sell
14,964,141
-5,165,175
-26% -$1.17B 0.59% 34
2022
Q3
$4.09B Buy
20,129,316
+224,264
+1% +$47.2M 0.67% 28
2022
Q2
$3.96B Sell
19,905,052
-256,171
-1% -$60.2M 0.5% 35
2022
Q1
$5.39B Sell
20,161,223
-995,553
-5% -$258M 0.54% 28
2021
Q4
$5.66B Sell
21,156,776
-1,519,616
-7% -$399M 0.51% 28
2021
Q3
$5.98B Sell
22,676,392
-4,055,729
-15% -$1.08B 0.56% 26
2021
Q2
$6.94B Sell
26,732,121
-1,083,048
-4% -$277M 0.64% 23
2021
Q1
$6.78B Sell
27,815,169
-2,074,564
-7% -$497M 0.68% 22
2020
Q4
$7.32B Buy
29,889,733
+364,668
+1% +$82.6M 0.75% 19
2020
Q3
$6.15B Buy
29,525,065
+329,934
+1% +$64.1M 0.71% 21
2020
Q2
$5.26B Sell
29,195,131
-804,143
-3% -$148M 0.66% 26
2020
Q1
$4.99B Buy
29,999,274
+1,120,066
+4% +$219M 0.79% 22
2019
Q4
$6.06B Sell
28,879,208
-2,033,332
-7% -$422M 0.79% 21
2019
Q3
$6.69B Sell
30,912,540
-1,207,938
-4% -$259M 0.95% 11
2019
Q2
$6.6B Sell
32,120,478
-901,635
-3% -$172M 0.93% 12
2019
Q1
$6.52B Buy
33,022,113
+199,605
+0.6% +$35.9M 0.96% 12
2018
Q4
$5.14B Buy
32,822,508
+565,248
+2% +$94.5M 0.87% 15
2018
Q3
$5.73B Buy
32,257,260
+2,514,838
+8% +$429M 0.84% 16
2018
Q2
$5.02B Buy
29,742,422
+2,159,540
+8% +$363M 0.77% 16
2018
Q1
$4.44B Buy
27,582,882
+1,113,352
+4% +$179M 0.71% 20
2017
Q4
$4.1B Buy
26,469,530
+675,360
+3% +$103M 0.66% 22
2017
Q3
$3.66B Buy
25,794,170
+3,264,714
+14% +$468M 0.63% 25
2017
Q2
$3.13B Buy
22,529,456
+2,698,993
+14% +$370M 0.56% 29
2017
Q1
$2.61B Buy
19,830,463
+41,233
+0.2% +$5.21M 0.49% 36
2016
Q4
$2.37B Buy
19,789,230
+2,286,136
+13% +$263M 0.47% 46
2016
Q3
$2.04B Buy
17,503,094
+1,022,233
+6% +$119M 0.41% 55
2016
Q2
$1.97B Buy
16,480,861
+655,573
+4% +$73.3M 0.42% 49
2016
Q1
$1.7B Buy
15,825,288
+11,376,850
+256% +$1.12B 0.36% 61
2015
Q4
$413M Sell
4,448,438
-148,785
-3% -$14.2M 0.09% 247
2015
Q3
$433M Buy
4,597,223
+486,737
+12% +$48.2M 0.1% 234
2015
Q2
$393M Buy
4,110,486
+298,400
+8% +$28.3M 0.08% 274
2015
Q1
$352M Sell
3,812,086
-192,476
-5% -$17.9M 0.07% 314
2014
Q4
$378M Sell
4,004,562
-448,134
-10% -$39.8M 0.08% 289
2014
Q3
$360M Buy
4,452,696
+105,510
+2% +$8.68M 0.08% 292
2014
Q2
$367M Sell
4,347,186
-3,391,995
-44% -$277M 0.08% 300
2014
Q1
$631M Buy
7,739,181
+497,226
+7% +$39.5M 0.14% 182
2013
Q4
$544M Sell
7,241,955
-1,029,094
-12% -$75.1M 0.12% 197
2013
Q3
$559M Sell
8,271,049
-78,378
-0.9% -$5.41M 0.14% 189
2013
Q2
$540M Buy
+8,349,427
New +$554M 0.14% 184

Other funds holding SYK

T. Rowe Price Associates's SYK Position: Q1 2026 in Review

T. Rowe Price Associates reduced its Stryker (SYK) stake by 0.8% in Q1 2026, selling an estimated $29.1M and leaving 10,037,137 shares worth $3.3B. The position accounts for 0.38% of the portfolio, ranked #45.

T. Rowe Price Associates first reported a position in SYK in Q2 2013 and has held it in 52 quarters since. The position peaked at $7.32B in Q4 2020. 2,293 funds tracked by Wall St. Rank hold SYK as of Q1 2026.

  • T. Rowe Price Associates held 10,037,137 shares of Stryker worth $3.3B as of Q1 2026.
  • T. Rowe Price Associates sold 80,927 Stryker shares in Q1 2026, an estimated $29.1M.
  • Stryker made up 0.38% of T. Rowe Price Associates's portfolio in Q1 2026, its #45 holding.
  • T. Rowe Price Associates first reported a position in Stryker in Q2 2013 and has held it in 52 quarters since.
  • T. Rowe Price Associates's Stryker position peaked at $7.32B in Q4 2020.
  • 2,293 funds tracked by Wall St. Rank held Stryker as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.